SCHEMBL5552306

SCHEMBL5552306

C=CCOS(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL667596 0.77 CYP2C19 (0.33)
SCHEMBL7706446 0.74
SCHEMBL5552302 0.72
SCHEMBL667597 0.72
SCHEMBL3522167 0.72
SCHEMBL22378579 0.72
SCHEMBL7701588 0.72
SCHEMBL15415704 0.72
SCHEMBL10811395 0.70
SCHEMBL2777129 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3021860-A1 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS Leptrex Ltd. (GB) 2016-05-25 EP claimed
WO-2015008019-A1 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS LEPTREX LTD (GB) 2015-01-22 WO claimed
WO-2014009759-A2 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS LEPTREX LTD (GB) 2014-01-16 WO claimed
WO-2007089685-A2 COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) 2007-08-09 WO claimed
WO-2006039285-A2 COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2006-04-13 WO claimed
US-9707201-B2 Allium extracts LEPTREX LTD (GB) 2017-07-18 US disclosed
US-20160151324-A1 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS LEPTREX LTD (GB) 2016-06-02 US disclosed
EP-3021860-A1 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS Leptrex Ltd. (GB) 2016-05-25 EP disclosed
WO-2015008019-A1 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS LEPTREX LTD (GB) 2015-01-22 WO disclosed
WO-2014009759-A2 IMPROVEMENTS IN OR RELATING TO ALLIUM EXTRACTS LEPTREX LTD (GB) 2014-01-16 WO disclosed
EP-2403827-B1 PROCESS FOR THE PREPARATION OF AJOENE NEEM BIOTECH LTD (GB) 2013-05-08 EP disclosed
WO-2007089685-A2 COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) 2007-08-09 WO disclosed
WO-2006039285-A2 COMPOSITIONS AND METHODS FOR INDUCING ADIPOSE TISSUE CELL DEATH THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2006-04-13 WO disclosed
WO-2003075901-A2 USE OF S-SUBSTITUTED L-CRYSTEINE FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS GHISALBERTI CARLO (BR) 2003-09-18 WO disclosed
US-4643994-A ANTICOAGULANTS, ANTIBIOTICS THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1987-02-17 US disclosed
EP-0185324-A2 Novel organic trithio oxides and method for the preparation thereof THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 1986-06-25 EP disclosed